Or click one of the links below: GNTI-122-T1D-1001 This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood Investigator Brittany S Bruggeman Status Accepting Candidates Ages 18 Years - 55 Years Sexes All TN-36 This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis)
No study has definitively shown BPC-157 causes cancer in humans, and no vascular tumors have appeared in animal models with prolonged use
In addition to exploring the diagnostic and therapeutic potential of stem cells, elucidating the requirements for endometrial receptivity may yield answers relevant to aging
Folate is naturally found in foods such as leafy green vegetables, citrus fruits, beans, and fortified grains